Compugen to Present at the Oppenheimer Healthcare Conference in New York
November 24 2015 - 7:00AM
Business Wire
Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug
discovery company, today announced that Ari Krashin, Chief
Financial Officer of Compugen, will present a corporate overview
and update at the Oppenheimer 26th Annual Healthcare Conference in
New York, on Tuesday, December 8, 2015.
About Compugen
Compugen is a leading drug discovery company utilizing its
broadly applicable predictive discovery infrastructure to identify
novel drug targets and develop first-in-class biologics. The
Company’s current pipeline primary focus is on immune checkpoint
target candidates discovered by the Company, potentially providing
the basis for a next wave of therapeutics for cancer immunotherapy.
Compugen’s business model is based on selectively entering into
collaborations for its novel targets and drug product candidates at
various stages of research and development under revenue-sharing
agreements. The Company is headquartered in Tel Aviv, Israel, with
R&D facilities in Tel Aviv and South San Francisco. At the US
facilities, monoclonal antibody therapeutic candidates are
discovered and developed against the Company’s novel target
candidates. For additional information, please visit Compugen's
corporate website at www.cgen.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151124005382/en/
Compugen Ltd.Tsipi Haitovsky, +972-52-598-9892Global Media
Liaisontsipih@cgen.com
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Compugen (NASDAQ:CGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024